These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3678477)

  • 1. A synthetic hemoregulatory peptide (HP5B) inhibits human myelopoietic colony formation (CFU-GM) but not leukocyte phagocytosis in vitro.
    Laerum OD; Sletvod O; Bjerknes R; Paukovits WR
    Eur J Haematol; 1987 Sep; 39(3):259-66. PubMed ID: 3678477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a hemoregulatory peptide (HP5b) on erythroid and myelopoietic colony formation in vitro.
    Kreja L; Hågå P; Muller-Bérat N; Laerum OD; Sletvold O; Paukovits WR
    Scand J Haematol; 1986 Aug; 37(2):79-86. PubMed ID: 3764340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro.
    Laerum OD; Sletvold O; Bjerknes R; Eriksen JA; Johansen JH; Schanche JS; Tveterås T; Paukovits WR
    Exp Hematol; 1988 May; 16(4):274-80. PubMed ID: 3258825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of hemoregulatory peptide (HP5b) action in culture.
    Laerum OD; Aakvaag A; Frostad S; Kalland T; Langen P; Maurer HR
    Int J Cell Cloning; 1990 Nov; 8(6):431-44. PubMed ID: 2273297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
    Frostad S; Kalland T; Aakvaag A; Laerum OD
    Stem Cells; 1993 Jul; 11(4):303-11. PubMed ID: 8401253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice.
    Alisauskas RM; Goldenberg DM; Sharkey RM; Blumenthal RD
    Int J Cancer; 1997 Jan; 70(3):323-9. PubMed ID: 9033635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
    Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
    Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
    Laerum OD; Paukovits WR
    Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636.
    Veiby OP; LoCastro S; Bhatnagar P; Olsen WM
    Stem Cells; 1996 Mar; 14(2):215-24. PubMed ID: 8991541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures.
    Veiby OP; Løvhaug D; Fjerdingstad H; Engelsen SJ
    Exp Hematol; 1992 Feb; 20(2):192-5. PubMed ID: 1544388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sequence of the hemoregulatory peptide is present in Gi alpha proteins.
    Laerum OD; Frostad S; Tøn HI; Kamp D
    FEBS Lett; 1990 Aug; 269(1):11-4. PubMed ID: 2117550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherent-cell-dependent stimulation of CFU-GM by nucleobases, nucleosides, their analogues, and the hemoregulatory peptide dimer.
    Langen P; Schunck H; Hunger B; Schütt M; Laerum OD
    Exp Hematol; 1992 Feb; 20(2):196-200. PubMed ID: 1544389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
    Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
    Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood leukocyte alterations in mice induced by a hemoregulatory pentapeptide (HP 5b).
    Laerum OD; Paukovits WR
    Leuk Res; 1985; 9(8):1075-84. PubMed ID: 3840221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of murine hemopoiesis in vivo by a synthetic hemoregulatory pentapeptide (HP 5b).
    Laerum OD; Paukovits WR
    Differentiation; 1984; 27(2):106-12. PubMed ID: 6548197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
    Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
    Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5.
    King AG; Talmadge JE; Badger AM; Pelus LM
    Exp Hematol; 1992 Feb; 20(2):223-8. PubMed ID: 1544391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and chemical properties of the hemoregulatory peptide and possibilities for clinical applications.
    Laerum OD; Paukovits WR
    Pharmacol Ther; 1989; 44(3):335-49. PubMed ID: 2519347
    [No Abstract]   [Full Text] [Related]  

  • 20. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.